As Global Head of Johnson & Johnson Innovation, JLABS (JLABS), Melinda Richter fosters the Johnson & Johnson Family of Companies external R&D engine and supports the innovation community by creating capital-efficient commercialization models that give early stage companies a big company advantage.
By providing infrastructure, services, educational programs and networks in global hotspots, JLABS is the best place to start a company working in healthcare, with a specific emphasis on Johnson & Johnson’s sectors: consumer, medical device and pharmaceuticals.
You’ve answered some basic science questions about a medical devices’s safety and are ready to move to the clinic. There is a lot to consider including study design, cost/incentives, speed, quality, the participant pool, communication/language, partners, your market, standard of medical care, data integrity and more! To answer these questions, we've assembled a group of experts to help you prepare before you take the next steps.